These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7536875

  • 81. Human Immunoglobulins for intravenous use and hepatitis C viral transmission.
    Slade HB.
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):613-9. PubMed ID: 8556510
    [No Abstract] [Full Text] [Related]

  • 82. Hepatitis C virus.
    Pereira C, Lee CA, Dusheiko G.
    BMJ; 1991 Sep 28; 303(6805):783. PubMed ID: 1657257
    [No Abstract] [Full Text] [Related]

  • 83. Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data.
    Yap PL.
    Clin Ther; 1996 Sep 28; 18 Suppl B():43-58. PubMed ID: 8930441
    [Abstract] [Full Text] [Related]

  • 84. Spurious outbreak of HCV in bone-marrow recipients treated with cytomegalovirus immunoglobulin.
    Ward KN, Morgan G, Ashworth K, Bremner J, O'Callaghan A, Teo CG.
    Lancet; 1992 Nov 21; 340(8830):1290-1. PubMed ID: 1359345
    [No Abstract] [Full Text] [Related]

  • 85. HCV and Gammagard in France.
    Gomperts ED.
    Lancet; 1994 Jul 16; 344(8916):201. PubMed ID: 7912801
    [No Abstract] [Full Text] [Related]

  • 86. Safety of anti-HCV-reactive immunoglobulin in heart transplant patients.
    Donegani E, di Summa M, Bobbio M, Ghisetti V, Marchiaro G, Rizzetto M, Bonino F.
    Lancet; 1992 Oct 24; 340(8826):1039. PubMed ID: 1383660
    [No Abstract] [Full Text] [Related]

  • 87. Infectious hazards of immune globulin.
    Barton LL.
    J Pediatr; 1995 Feb 24; 126(2):321-2. PubMed ID: 7844688
    [No Abstract] [Full Text] [Related]

  • 88. Should we transplant hepatitis C-positive organs?
    Lee WM.
    Gastroenterology; 1993 Jul 24; 105(1):300-2. PubMed ID: 8390380
    [No Abstract] [Full Text] [Related]

  • 89. Intravenous immunoglobulins.
    Webster AD.
    BMJ; 1991 Aug 17; 303(6799):375-6. PubMed ID: 1912799
    [No Abstract] [Full Text] [Related]

  • 90. Infection with hepatitis G virus in immunoglobulin recipients.
    Lefrère JJ, Ravera N, Corbi C, Mariotti M, Loiseau P.
    Lancet; 1997 Jan 18; 349(9046):206. PubMed ID: 9111561
    [No Abstract] [Full Text] [Related]

  • 91. Do antibodies to the hepatitis G virus E2 antigen in immunoglobulin products reduce infectivity?
    Cristiano K, Bisso G, Wirz M, Gentili G.
    Transfusion; 1999 Jan 18; 39(11-12):1271-2. PubMed ID: 10604257
    [No Abstract] [Full Text] [Related]

  • 92. Hepatitis C virus transmission following invasive medical procedures.
    Delwaide J, Gérard C, Vaira D, Maggipinto G, Rentier B, Belaiche J.
    J Intern Med; 1999 Jan 18; 245(1):107-8. PubMed ID: 10095825
    [No Abstract] [Full Text] [Related]

  • 93. Passively transfused hepatitis C antibody.
    Kudesia G, Price C, Clewley J.
    Lancet; 1992 Nov 21; 340(8830):1291. PubMed ID: 1359346
    [No Abstract] [Full Text] [Related]

  • 94. Administration of immune serum globulin following exposure to hepatitis C virus.
    Miller MA, Orenstein P, Amihod B.
    Clin Infect Dis; 1993 Feb 21; 16(2):335. PubMed ID: 7680238
    [No Abstract] [Full Text] [Related]

  • 95. Intravenous immunoglobulins and hepatitis C transmission in healthy pregnant women.
    Reznikoff-Etievant MF, de Lachaux Y, Marpeau L, Couroucé A.
    Lancet; 1992 Oct 17; 340(8825):986. PubMed ID: 1357402
    [No Abstract] [Full Text] [Related]

  • 96. Is safe always safe? Pooled plasma derivatives and viral hepatitis.
    Mosley JW.
    Gastroenterology; 1996 Apr 17; 110(4):1307-10. PubMed ID: 8613022
    [No Abstract] [Full Text] [Related]

  • 97. Infection with hepatitis C virus. Intravenous gammaglobulin may still infect patients.
    Quinti I, Sacco G, el Salman D, Paganelli R, Fiorilli M, Aiuti F, Pandolfi F.
    BMJ; 1994 Mar 26; 308(6932):856. PubMed ID: 7513219
    [No Abstract] [Full Text] [Related]

  • 98. Community-acquired hepatitis C virus infection.
    Hollinger FB, Lin HJ.
    Gastroenterology; 1992 Apr 26; 102(4 Pt 1):1426-9. PubMed ID: 1312978
    [No Abstract] [Full Text] [Related]

  • 99. Nanofiltration of immunoglobulin with 35-nm filters fails to remove substantial amounts of HCV.
    Eibl J, Barrett N, Hämmerle T, Dorner F.
    Biologicals; 1996 Sep 26; 24(3):285-7. PubMed ID: 8978927
    [No Abstract] [Full Text] [Related]

  • 100. Hepatitis G virus in intravenous immunoglobulin.
    Chen PJ, Kao JH, Chen DS.
    Gastroenterology; 1996 Nov 26; 111(5):1399-400. PubMed ID: 8898661
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.